Rimegepant sulfate
4 Inquiries
1374024-48-2
Shanghai Port
1kg;10kg
Yes
2023-08-05
Upadacitinib Hemihydrate,(S)-(+)-1-Boc-3-hydroxypyrrolidine
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceRimegepant sulfate is a small molecule, highly selective calcitonin gene-related peptide antagonist (CGRP) developed by Biohaven Pharmaceutical Holdings, Inc. and approved by the FDA for the acute treatment of migraine. rimegepant and ubrogepant are the only CGRP antagonists with oral bioavailability. Because of the absence of vasoconstrictive properties observed with oral CGRP antagonists, the use of rimegepant is safer and more reliable in patients with contraindications to standard therapy[1].Basic Info
-
Product Name:
Rimegepant sulfate
Other Name:[(5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl]4-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate;(5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate hemisulfate sesquihydrate;RIMEGEPANT SULFATE;Rimegepant sulfate hydrate【Chemical name：1-Piperidinecarboxylic acid, 4-(2,3-dihydro-2-oxo-1H-imidazo[4,5-b]pyridin-1-yl)-, (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl ester, sulfate, hydrate (2:1:3)】;(5S,6S,9R)-5-amino-6-(2,3difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b] pyridin-9-yl4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)-1-piperidinecarboxylate hemisulfate sesquihydrate;Rimegepant sulfate hydrate;Rimegepant hemisulfate sesquihydrate;Rimegepant 1/2Sulfate 3/2Trihydrate
CAS No.:1374024-48-2
Molecular Formula:C28H30F2N6O7S
InChIKeys:SBWRYPRKGHWPOH-FDZFFRPLNA-N
Molecular Weight:632.64
EC Number:822-372-0
Categories:
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Upadacitinib Hemihydrate,(S)-(+)-1-Boc-3-hydroxypyrrolidine
-
Location:
Honggutan District, Nanchang City, Jiangxi Province
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
50 days
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
11-50
-
Year of Establishment:
2021
-
-
Inquiry History4 Inquiries
Country Product Purchase Quantity Date Posted 
Pakistan
Rimegepant Sulfate Lyopholised
1 20' Fcl May 6, 2026 
Bangladesh
Rimegepant Sulfate
25 KG Jul 21, 2025 
United Kingdom
Rimegepant sulfate
1 MT Jul 21, 2025 
United States
Rimegepant Sulfate
1 MT May 20, 2024 Post an enquiry for this product
